The rotenone model of Parkinson's disease
- 1 July 2003
- journal article
- letter
- Published by Elsevier in Trends in Neurosciences
- Vol. 26 (7) , 345-346
- https://doi.org/10.1016/s0166-2236(03)00144-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in ratsJournal of Neurochemistry, 2003
- Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein AggregationExperimental Neurology, 2003
- Functional coupling of PSST and ND1 subunits in NADH:ubiquinone oxidoreductase established by photoaffinity labelingBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2001
- Chronic systemic pesticide exposure reproduces features of Parkinson's diseaseNature Neuroscience, 2000
- Increased striatal dopamine turnover following acute administration of rotenone to miceBrain Research, 2000
- MPTP induces alpha-synuclein aggregation in the substantia nigra of baboonsNeuroReport, 2000
- Replicating Huntington's disease phenotype in experimental animalsProgress in Neurobiology, 1999
- Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigraBrain Research, 1997
- Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeysAnnals of Neurology, 1986
- Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicityNeuroscience Letters, 1985